Effect of specialised versus generalised outpatient treatment for bipolar disorder : the CAG Bipolar trial - study protocol for a randomised controlled trial
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
INTRODUCTION: Despite current available treatment patients with bipolar disorder often experience relapses and decreased overall functioning. Furthermore, patients with bipolar disorder are often not treated medically or psychologically according to guidelines and recommendations. A Clinical Academic Group is a new treatment initiative bringing together clinical services, research, education and training to offer care and treatment that is based on reliable evidence backed up by research. The present Clinical Academic Group for bipolar disorder (the CAG Bipolar) randomised controlled trial (RCT) aims for the first time to investigate whether specialised outpatient treatment in CAG Bipolar versus generalised community-based treatment improves patient outcomes and clinician's satisfaction with care in patients with bipolar disorder.
METHODS AND ANALYSIS: The CAG Bipolar trial is a pragmatic randomised controlled parallel-group trial undertaken in the Capital Region of Denmark covering a catchment area of 1.85 million people. Patients with bipolar disorder are invited to participate as part of their outpatient treatment in the Mental Health Services. The included patients will be randomised to (1) specialised outpatient treatment in the CAG Bipolar (intervention group) or (2) generalised community-based outpatient treatment (control group). The trial started 13 January 2020 and has currently included more than 600 patients. The outcomes are (1) psychiatric hospitalisations and cumulated number and duration of psychiatric hospitalisations (primary), and (2) self-rated depressive symptoms, self-rated manic symptoms, quality of life, perceived stress, satisfaction with care, use of medication and the clinicians' satisfaction with their care (secondary). A total of 1000 patients with bipolar disorder will be included.
ETHICS AND DISSEMINATION: The CAG Bipolar RCT is funded by the Capital Region of Denmark and ethical approval has been obtained from the Regional Ethical Committee in The Capital Region of Denmark (H-19067248). Results will be published in peer-reviewed academic journals, presented at scientific meetings and disseminated to patient organisations and media outlets.
TRIAL REGISTRATION NUMBER: NCT04229875.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
BMJ open - 11(2021), 10 vom: 13. Okt., Seite e048821 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kessing, Lars Vedel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adult psychiatry |
|---|
| Anmerkungen: |
Date Completed 02.11.2021 Date Revised 02.11.2021 published: Electronic ClinicalTrials.gov: NCT04229875 Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjopen-2021-048821 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331864223 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331864223 | ||
| 003 | DE-627 | ||
| 005 | 20231226203716.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjopen-2021-048821 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1106.xml |
| 035 | |a (DE-627)NLM331864223 | ||
| 035 | |a (NLM)34645661 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kessing, Lars Vedel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of specialised versus generalised outpatient treatment for bipolar disorder |b the CAG Bipolar trial - study protocol for a randomised controlled trial |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.11.2021 | ||
| 500 | |a Date Revised 02.11.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT04229875 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a INTRODUCTION: Despite current available treatment patients with bipolar disorder often experience relapses and decreased overall functioning. Furthermore, patients with bipolar disorder are often not treated medically or psychologically according to guidelines and recommendations. A Clinical Academic Group is a new treatment initiative bringing together clinical services, research, education and training to offer care and treatment that is based on reliable evidence backed up by research. The present Clinical Academic Group for bipolar disorder (the CAG Bipolar) randomised controlled trial (RCT) aims for the first time to investigate whether specialised outpatient treatment in CAG Bipolar versus generalised community-based treatment improves patient outcomes and clinician's satisfaction with care in patients with bipolar disorder | ||
| 520 | |a METHODS AND ANALYSIS: The CAG Bipolar trial is a pragmatic randomised controlled parallel-group trial undertaken in the Capital Region of Denmark covering a catchment area of 1.85 million people. Patients with bipolar disorder are invited to participate as part of their outpatient treatment in the Mental Health Services. The included patients will be randomised to (1) specialised outpatient treatment in the CAG Bipolar (intervention group) or (2) generalised community-based outpatient treatment (control group). The trial started 13 January 2020 and has currently included more than 600 patients. The outcomes are (1) psychiatric hospitalisations and cumulated number and duration of psychiatric hospitalisations (primary), and (2) self-rated depressive symptoms, self-rated manic symptoms, quality of life, perceived stress, satisfaction with care, use of medication and the clinicians' satisfaction with their care (secondary). A total of 1000 patients with bipolar disorder will be included | ||
| 520 | |a ETHICS AND DISSEMINATION: The CAG Bipolar RCT is funded by the Capital Region of Denmark and ethical approval has been obtained from the Regional Ethical Committee in The Capital Region of Denmark (H-19067248). Results will be published in peer-reviewed academic journals, presented at scientific meetings and disseminated to patient organisations and media outlets | ||
| 520 | |a TRIAL REGISTRATION NUMBER: NCT04229875 | ||
| 650 | 4 | |a Clinical Trial Protocol | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a adult psychiatry | |
| 650 | 4 | |a depression & mood disorders | |
| 650 | 4 | |a organisation of health services | |
| 700 | 1 | |a Kyster, Natacha Blauenfeldt |e verfasserin |4 aut | |
| 700 | 1 | |a Bondo-Kozuch, Pernille |e verfasserin |4 aut | |
| 700 | 1 | |a Christensen, Ellen Margrethe |e verfasserin |4 aut | |
| 700 | 1 | |a Vejstrup, Birgitte |e verfasserin |4 aut | |
| 700 | 1 | |a Smidt, Birte |e verfasserin |4 aut | |
| 700 | 1 | |a Jørgensen, Anne-Marie Bangsgaard |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenberg, Raben |e verfasserin |4 aut | |
| 700 | 1 | |a Mardosas, Darius |e verfasserin |4 aut | |
| 700 | 1 | |a Rasmussen, Louise Behrend |e verfasserin |4 aut | |
| 700 | 1 | |a Vinberg, Maj |e verfasserin |4 aut | |
| 700 | 1 | |a Hageman, Ida |e verfasserin |4 aut | |
| 700 | 1 | |a Faurholt-Jepsen, Maria |e verfasserin |4 aut | |
| 700 | 0 | |a CAG Bipolar Study group |e verfasserin |4 aut | |
| 700 | 1 | |a Brøndmark, Kim |e investigator |4 oth | |
| 700 | 1 | |a Seidelin, Signe |e investigator |4 oth | |
| 700 | 1 | |a Bondo-Kozuch, Pernille |e investigator |4 oth | |
| 700 | 1 | |a Sarauw-Nielsen, Ida Palmblad |e investigator |4 oth | |
| 700 | 1 | |a Larsen, Annemette |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2012 |g 11(2021), 10 vom: 13. Okt., Seite e048821 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:10 |g day:13 |g month:10 |g pages:e048821 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2021-048821 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 10 |b 13 |c 10 |h e048821 | ||